BMS_CA240-0005
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
A Phase 2 Open-Label, Multi-Center Study of BMS-986504 as Monotherapy and in Combination with Other Agents in Participants with Advanced and/or Metastatic Solid Tumors with Homozygous MTAP Deletion (MountainTap-5)
Principal Investigator
Associate Professor of Medicine
Protocol Number
IRB:
PRO00120376
NCT:
NCT07492680
Phase
Phase
II
ClinicalTrials.gov
View on ClinicalTrials.gov
Status
OPEN TO ACCRUAL
Participate
Email hollie.watson@duke.edu